Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)

Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)

Background/Aims It remains to be determined whether switching from adefovir (ADV) to tenofovir (TDF) provides better virological outcomes in patients exhibiting suboptimal responses to ADV plus nucleoside analogue (ADV+NA) therapy for NA-resistant chronic hepatitis B (CHB). Methods In this prospecti...

Full description

Bibliographic Details
Main Authors: Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2016-12-01
Series:Clinical and Molecular Hepatology
Subjects:
Adefovir
Chronic hepatitis B
Complete virological response
Suboptimal response
Tenofovir
Online Access:http://e-cmh.org/upload/pdf/cmh-2016-0037.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-2016-0037.pdf

Similar Items